Isoniazid protection and risk of tuberculosis in patients who used anti tumor necrosis factor-alpha treatment

O. Elbek, S. Borekci, M. Uyar, N. Bayram, H. Bayram, O. Dikensoy (Gaziantep, Turkey)

Source: Annual Congress 2007 - New perspectives and old problems in diagnosing tuberculosis infection and disease
Session: New perspectives and old problems in diagnosing tuberculosis infection and disease
Session type: Oral Presentation
Number: 1775
Disease area: Respiratory infections

Congress or journal article abstractSlide presentationMultimedia filesE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
O. Elbek, S. Borekci, M. Uyar, N. Bayram, H. Bayram, O. Dikensoy (Gaziantep, Turkey). Isoniazid protection and risk of tuberculosis in patients who used anti tumor necrosis factor-alpha treatment. Eur Respir J 2007; 30: Suppl. 51, 1775

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases
Source: Eur Respir J 2009; 33: 586-593
Year: 2009



Re-activation of bovine tuberculosis in a patient treated with infliximab
Source: Eur Respir J 2008; 32: 229-231
Year: 2008



A screening for latent tuberculosis infection among candidates to anti-tumor necrosis factor-alpha agents using a whole blood interferon-gamma test
Source: Annual Congress 2008 - Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease
Year: 2008


The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement
Source: Eur Respir J 2010; 36: 1185-1206
Year: 2010



Use of tuberculin skin test, IFN-gamma release assays and IFN-gamma-induced protein-10 to identify children with TB infection
Source: Eur Respir J 2013; 41: 644-648
Year: 2013



Relationship between the whole blood interferon-gamma responses and the risk of active tuberculosis
Source: Annual Congress 2006 - New methods to diagnose tuberculosis infection
Year: 2006


Should isoniazid prophylaxis be prescribed to the patients under tumor necrosis factor-alpha antagonists independent of tuberculin skin test?
Source: International Congress 2015 – Screening strategies in TB
Year: 2015

Effect of prophylaxis on responses for ESAT-6/CFP-10 in whole blood IFN-g test
Source: Annual Congress 2005 - Genetics and immunobiology of tuberculosis
Year: 2005


Comparison of tuberculin skin test with an interferon-gamma based test in detecting candidates to latent tuberculosis infection treatment
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005


LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement
Source: Eur Respir J 2009; 33: 956-973
Year: 2009



Comparison of a T-cell-based assay with tuberculin skin testing (TST) for diagnosis of latent tuberculosis infection (LTBI) in contact-tracing procedures
Source: Annual Congress 2005 - Diagnosis of tuberculosis and LTBI
Year: 2005


New immunologic tools for the diagnosis and therapy of tuberculosis
Source: Annual Congress 2005 - Challenges in the management of pulmonary tuberculosis: a continuous clinical problem
Year: 2005

Implication of leptin, tumor necrosis factor-alpha, interleukin-1 and interleukin-6 in the pathogenesis of wasting in tuberculosis
Source: Annual Congress 2006 - Immunology of tuberculosis and diagnosis of tuberculosis infection
Year: 2006


Arginine as an adjuvant to chemotherapy improves clinical outcome in active tuberculosis
Source: Eur Respir J 2003; 21: 483-488
Year: 2003



Cost-effectiveness of interferon-γ release assay testing for the treatment of latent tuberculosis
Source: Eur Respir J 2007; 30: 321-332
Year: 2007



Serial interferon-gamma release assays for screening and monitoring of tuberculosis infection during treatment with biologic agents
Source: Annual Congress 2013 –Tuberculosis and latent tuberculosis infection in subpopulations
Year: 2013

Using an interferon-γ assay for the diagnosis of tuberculosis infection before using tumor necrosis factor-α blockers
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007


The incidence of tuberculosis in patients taking anti TNF alpha therapy
Source: Annual Congress 2011 - Tuberculosis in immunocompromised hosts
Year: 2011

Comparison between the antigen-specific interferon-gamma assay and the tuberculin skin testing for the detection of tuberculosis infection among BCG vaccinated schoolers at risk for tuberculosis exposure
Source: Annual Congress 2007 - Gamma-interferon-based tests to diagnose tuberculosis infection and disease
Year: 2007


Concordance between tuberculin skin testing and interferon-gamma release assays in diagnosis of latent tuberculosis infection among HIV-infected individuals
Source: Annual Congress 2012 - Tuberculosis and immunologic assays
Year: 2012